Indications and uses
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
before using this product read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: vaginal insert: with the applicator, place the vaginal insert into the vagina. Throw applicator away after use. external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vulva). Us...
do not use if printed sealed pouch is torn, open or incompletely sealed do not use if seal over tube opening has been punctured do not purchase if carton is open store at 20°-25°C (68°-77°F) this is a 1-dose treatment. Most women do not get complete relief of their symptoms in just 1 day. Most women get some improvement in 1 day and complete relief by 7 days.
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Miconazole nitrate 1200 mg (in vaginal insert) | Vaginal antifungal |
| Miconazole nitrate 2% (external cream) | Vaginal antifungal |
For vaginal use only
Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
vaginal insert: gelatin, glycerin, lecithin, mineral oil, titanium dioxide, white petrolatum
external cream: benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol
call toll-free 877-666-4782
Distributed by: INSIGHT Pharmaceuticals, LLC., Trevose, PA 19053
MONISTAT®
Miconazole Nitrate Vaginal Insert (1200 mg) and Miconazole Nitrate Cream (2%)
VAGINAL ANTIFUNGAL | COMBINATION PACK
CLINICALLY PROVEN
MULTI-SYMPTOM RELIEF
#1 DOCTOR
RECOMMENDED BRAND†
1
1-DAY
MAXIMUM
STRENGTH
TREATMENT
OVULE®
Net Wt. 1 OVULE® Insert • 0.32oz (9g) tube

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63736-001-01 | 2020-06-29 | C162847 | 48780-1 | 9d75b9d0-9fdc-f424-e053-dadaa90a57ce | Monistat ® 1 Combination Pack Triple Action |
| 63736-001-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9fdc-f424-e053-dadaa90a57ce | Monistat ® 1 Combination Pack Triple Action |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Miconazole Nitrate | ACTIVE INGREDIENT | VW4H1CYW1K | 2 | |
| Miconazole | ACTIVE MOIETY | 7NNO0D7S5M | 2 | |
| Benzoic Acid | INACTIVE INGREDIENT | 8SKN0B0MIM | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Isopropyl Myristate | INACTIVE INGREDIENT | 0RE8K4LNJS | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 2 | |
| Potassium Hydroxide | INACTIVE INGREDIENT | WZH3C48M4T | 2 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| Stearyl Alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-001 | 63736-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Miconazole Nitrate | VW4H1CYW1K | ACTIB |
| Gelatin | 2G86QN327L | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
| Titanium Dioxide | 15FIX9V2JP | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
| Miconazole Nitrate | VW4H1CYW1K | ACTIB |
| Benzoic Acid | 8SKN0B0MIM | IACT |
| Cetyl Alcohol | 936JST6JCN | IACT |
| Isopropyl Myristate | 0RE8K4LNJS | IACT |
| Polysorbate 60 | CAL22UVI4M | IACT |
| Potassium Hydroxide | WZH3C48M4T | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Water | 059QF0KO0R | IACT |
| Stearyl Alcohol | 2KR89I4H1Y | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Gelatin | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | MOUTHWASH / BUCCAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | SUPPOSITORY / VAGINAL | 2 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRAMUSCULAR | 16 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | LOTION / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / TOPICAL | 0.1 %w/w | ||
| Potassium Hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / INTRAVASCULAR | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | GEL / RECTAL | 11 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| Potassium Hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | AEROSOL, FOAM / TOPICAL | 30 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | PASTILLE / ORAL | 143 mg | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL / TOPICAL | 9.3 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| Gelatin | GELATIN | 2G86QN327L | GUM, CHEWING / BUCCAL | 102 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Benzoic Acid | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / ORAL | 100 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / VAGINAL | 50 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| Potassium Hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE / ORAL | 172 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET / ORAL | 46 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021308-001 | MONISTAT 1 COMBINATION PACK | MICONAZOLE NITRATE | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021308-001 | MONISTAT 1 COMBINATION PACK | 2%,1.2GM | CREAM, INSERT / TOPICAL, VAGINAL | RLD, RS | 2001-06-29 | f41ea6bd6efb… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021308-001 | 6153635 | 2020-11-28 | Delist requested | ea99ee380514… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 68dec81a-4013-4bc8-af51-0016c3ce6bb1 | a137262d-d01f-4880-8966-143914050f71 | 2020-06-29 | Warnings | 68dec81a-4013-4bc8-af51-0016c3ce6bb1 a137262d-d01f-4880-8966-143914050f71 |
Adverse event summaries are temporarily unavailable. Other product information remains available.